Table 1.
Clinical features
| Patient | Age (yr)/sex | Infection | Cryoglobulin | HCV | C3 (mg/dl) | Presenting SCr (mg/dl) | Treatment | Follow-up time (mo) | Outcome |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 33/F | Bullous impetigo | Negative | Negative | N/A | 3.7 | Antibiotic + CS | 1 | HD |
| #2 | 62/M | MSSA/osteomyelitis, bacteremia | Negative | Positive | 83 | 4.3 | Antibiotic + CS | 3 | HD |
| #3 | 75/M | MSSA/foot ulcer | Positive | Negative | 41 | 4 | Antibiotic | 9 | HD |
| #4 | 63/F | MSSA/epidural abscess, bacteremia | N/A | Negative | 60 | 1.7 | Antibiotic | 2 | SCr: 0.75 mg/dl |
| #5 | 61/M | MSSA/diabetic foot, bacteremia | N/A | N/A | 85 | 6 | Antibiotic | 6 | HD/Expired |
CS, corticosteroids; HCV, hepatitis C virus; HD, hemodialysis; MSSA, methicillin-susceptible Staphylococcus aureus; SCr, serum creatinine.